Cramer Remix: GE's CEO has breathed new life into a fallen franchise

In This Article:

  • General Electric CEO Larry Culp simplified the company's reporting techniques and is breathing new life into the fallen franchise, CNBC's Jim Cramer says.

  • "It's the most un-GE piece of correspondence I've ever seen. The culture shock here is downright stunning," the "Mad Money" host says.

  • Cramer interviews CEOs of GW Pharmaceuticals, Cyberark, and Clean Harbors.

General Electric GE CEO Larry Culp has simplified the company's report techniques and could be on the right path to fix the challenges in its power division, CNBC's Jim Crame r said Wednesday.

Culp, who became chief of GE in September, delivered his first annual letter to shareholders on Tuesday that Cramer said made a significant departure from pages of "incomprehensible" numbers about each of the conglomerate's businesses. The annual report laid out the 2018 performances of all eight segments on one condensed page.

"It's honest, it's forthright, it's straightforward, and short," the "Mad Money" host said. "It's the most un-GE piece of correspondence I've ever seen. The culture shock here is downright stunning."

Click here to find out why Cramer thinks Culp can revive the company's power business.

How to sleep like a baby

If investors want to start sleeping better at night, it's time to start thinking about what's going right with this economy, Cramer said.

While many Wall Street watchers have been fixated on what could go wrong on the market, the host explained six reasons he can't stop wiping sleep from his own eyes.

"Now, I know many of you probably think I'm whistling past the graveyard here," Cramer said. "I'm only whistling past the graveyard of underperforming portfolio managers who can't sleep at night because they've been scared away from a terrific rally by the parade of horribles that play like a constant loop inside their heads."

The United States economy is the strongest in the world and benefits from a two-punch combo that the host has never seen before, Cramer said. A "fabulous" employment rate on top of almost non-existent inflation should relive a lot of stock picker's worries, he said.

With the days inching closer to March, the last month of the first quarter in 2019, Cramer is anticipating the jobs report set to come out Friday.

Learn how to sleep free of worry like Cramer here .

It's not what you may think it is

GW Pharmaceuticals GW2-FF ' stock price shot up less than 14 percent during Wednesday's session coming off of its latest earnings report. In November, the biopharmaceutical company launched its first commercial drug called Epidiolex, which is an FDA-approved plant-derived cannabinoid medicine to treat patients with epilepsy.